Philadelphia Trust Company’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-116,237
Closed -$9.2M 246
2021
Q4
$9.2M Sell
116,237
-12,141
-9% -$1.02M 0.67% 42
2021
Q3
$10.1M Sell
128,378
-3,823
-3% -$307K 0.75% 40
2021
Q2
$10.4M Sell
132,201
-3,184
-2% -$244K 0.72% 41
2021
Q1
$10.2M Sell
135,385
-17,578
-11% -$1.29M 0.78% 39
2020
Q4
$10.1M Buy
+152,963
New +$8.94M 0.82% 37

Other funds holding ENOV

Philadelphia Trust Company's ENOV Position: Q1 2022 in Review

Philadelphia Trust Company sold out of Enovis (ENOV) in Q1 2022, closing a stake of 116,237 shares — an estimated $9.2M sold.

Philadelphia Trust Company first reported a position in ENOV in Q4 2020 and held it in 5 quarters. The position peaked at $10.4M in Q2 2021. 298 funds tracked by Wall St. Rank hold ENOV as of Q1 2022.

  • Philadelphia Trust Company reported no remaining Enovis position as of Q1 2022 after selling out during the quarter.
  • Philadelphia Trust Company sold 116,237 Enovis shares in Q1 2022, an estimated $9.2M.
  • Philadelphia Trust Company first reported a position in Enovis in Q4 2020 and held it in 5 quarters.
  • Philadelphia Trust Company's Enovis position peaked at $10.4M in Q2 2021.
  • 298 funds tracked by Wall St. Rank held Enovis as of Q1 2022.

Based on Philadelphia Trust Company's 13F filing for Q1 2022, filed 5 May 2022.